Susquehanna International Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Sell
544,700
-28,600
-5% -$301K ﹤0.01% 4635
2025
Q4
$6.74M Buy
573,300
+239,100
+72% +$2.58M ﹤0.01% 3582
2025
Q3
$2.58M Buy
334,200
+26,200
+9% +$184K ﹤0.01% 5263
2025
Q2
$2.25M Buy
308,000
+85,300
+38% +$688K ﹤0.01% 5545
2025
Q1
$2.11M Sell
222,700
-161,600
-42% -$2.02M ﹤0.01% 5406
2024
Q4
$6.33M Sell
384,300
-90,100
-19% -$1.4M ﹤0.01% 3252
2024
Q3
$7M Buy
474,400
+45,600
+11% +$714K ﹤0.01% 3090
2024
Q2
$5.95M Sell
428,800
-158,500
-27% -$2.25M ﹤0.01% 3171
2024
Q1
$9.23M Buy
587,300
+63,800
+12% +$985K ﹤0.01% 2717
2023
Q4
$8.47M Buy
523,500
+390,800
+294% +$6.39M ﹤0.01% 2873
2023
Q3
$1.63M Sell
132,700
-300
-0.2% -$4.46K ﹤0.01% 5558
2023
Q2
$2.14M Sell
133,000
-46,900
-26% -$773K ﹤0.01% 5013
2023
Q1
$3.13M Buy
179,900
+45,700
+34% +$651K ﹤0.01% 4247
2022
Q4
$1.24M Sell
134,200
-47,100
-26% -$439K ﹤0.01% 5725
2022
Q3
$1.56M Buy
181,300
+29,400
+19% +$292K ﹤0.01% 5496
2022
Q2
$1.24M Buy
151,900
+123,900
+443% +$1.18M ﹤0.01% 6003
2022
Q1
$340K Sell
28,000
-1,600
-5% -$33.7K ﹤0.01% 9970
2021
Q4
$1.01M Sell
29,600
-70,600
-70% -$2.76M ﹤0.01% 7267
2021
Q3
$4.83M Buy
100,200
+16,200
+19% +$750K ﹤0.01% 4015
2021
Q2
$3.79M Sell
84,000
-9,600
-10% -$425K ﹤0.01% 4539
2021
Q1
$4.51M Buy
93,600
+38,500
+70% +$2M ﹤0.01% 4107
2020
Q4
$2.97M Buy
55,100
+9,400
+21% +$425K ﹤0.01% 4330
2020
Q3
$1.69M Sell
45,700
-37,900
-45% -$1.41M ﹤0.01% 4948
2020
Q2
$2.59M Sell
83,600
-43,900
-34% -$1.22M ﹤0.01% 4044
2020
Q1
$3.52M Buy
+127,500
New +$3.82M ﹤0.01% 3047
2019
Q3
Sell
-48,500
Closed -$1.06M 10609
2019
Q2
$1.06M Sell
48,500
-87,800
-64% -$1.93M ﹤0.01% 5503
2019
Q1
$2.79M Buy
136,300
+74,700
+121% +$1.3M ﹤0.01% 3237
2018
Q4
$777K Buy
61,600
+28,400
+86% +$423K ﹤0.01% 5170
2018
Q3
$510K Buy
+33,200
New +$459K ﹤0.01% 6482
2018
Q2
Sell
-25,400
Closed -$207K 10120
2018
Q1
$207K Sell
25,400
-4,400
-15% -$35.6K ﹤0.01% 8270
2017
Q4
$264K Sell
29,800
-29,500
-50% -$272K ﹤0.01% 7806
2017
Q3
$660K Buy
+59,300
New +$577K ﹤0.01% 6034
2017
Q2
Sell
-34,400
Closed -$271K 9598
2017
Q1
$271K Sell
34,400
-4,400
-11% -$35.8K ﹤0.01% 7504
2016
Q4
$333K Buy
38,800
+28,400
+273% +$243K ﹤0.01% 7781
2016
Q3
$85K Buy
+10,400
New +$87.3K ﹤0.01% 8003
2016
Q2
Sell
-51,800
Closed -$349K 9063
2016
Q1
$349K Buy
51,800
+3,000
+6% +$19.7K ﹤0.01% 7019
2015
Q4
$384K Buy
+48,800
New +$357K ﹤0.01% 7256
2015
Q3
Sell
-22,000
Closed -$119K 9973
2015
Q2
$119K Buy
22,000
+11,700
+114% +$60.3K ﹤0.01% 9606
2015
Q1
$48K Buy
+10,300
New +$44.8K ﹤0.01% 9159
2014
Q4
Sell
-24,100
Closed -$126K 9941
2014
Q3
$126K Sell
24,100
-3,400
-12% -$17.5K ﹤0.01% 8988
2014
Q2
$91K Buy
27,500
+10,100
+58% +$33.6K ﹤0.01% 9448
2014
Q1
$60K Buy
+17,400
New +$65.2K ﹤0.01% 8685

Other funds holding NEO

Susquehanna International Group's NEO Position: Q1 2026 in Review

Susquehanna International Group increased its NeoGenomics (NEO) stake by 230% in Q1 2026, buying an estimated $348K and bringing the position to 47,452 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #10518.

Susquehanna International Group first reported a position in NEO in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.23M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Susquehanna International Group held 47,452 shares of NeoGenomics worth $352K as of Q1 2026.
  • Susquehanna International Group bought 33,082 NeoGenomics shares in Q1 2026, an estimated $348K.
  • NeoGenomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10518 holding.
  • Susquehanna International Group first reported a position in NeoGenomics in Q4 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's NeoGenomics position peaked at $5.23M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.